Perioperative Antibiotics in the Setting of Oropharyngeal Reconstruction
Authors:
- Brendan M. FinnertyBFBrendan M. Finnerty
- Alyssa Reiffel GolasAGAlyssa Reiffel Golas
- Jill J. KetnerJKJill J. Ketner
- Andrew WeinsteinAWAndrew Weinstein
- Tatiana BoykoTBTatiana Boyko
- Christine H. RohdeCRChristine H. Rohde
- David KutlerDKDavid Kutler
- Jason A. SpectorJSJason A. Spector
- 1 June 2016
- journal article
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 76 (6) , 663-667
Abstract
Recipient-site infection after oropharyngeal reconstruction is a potentially disastrous complication. Although studies suggest that perioperative antibiotics reduces infection rates in these patients from 87% to 20%, there is no consensus regarding what constitutes the most appropriate antibiotic regimen and duration of treatment. A retrospective review of perioperative antibiotic administration was performed of all patients who underwent local, pedicled, or free flap oropharyngeal reconstruction after oncologic resection by a single surgeon at a single institution between 2007 and 2013 to assess for recipient-site complications. Ninety-seven patients underwent 100 reconstructions (61 free flap reconstructions, 39 pedicled/local flap reconstructions) and all received a combination of intravenous (IV) antibiotic agents designed to cover oral flora. There were 23 (23%) recipient-site complications, which included cellulitis (9%), mucocutaneous fistula (5%), abscess (5%), and wound dehiscence (4%). Duration of antibiotic prophylaxis, defined as less than 48 hours (short-course) or greater than 48 hours (long-course), was not a significant predictor of recipient-site complication. Significant risk factors for recipient-site complications were clindamycin prophylaxis (P < 0.008), increased duration of surgery (P < 0.047), and advanced age (P < 0.034). Recipient-site complication was found to be a significant predictor of both increased length of hospital stay (P < 0.001) and increased time to the resumption of enteral feeds (P < 0.035). These data suggest that extended courses of perioperative antibiotics do not confer additional benefits in patients undergoing oropharyngeal reconstruction. We recommend a limited 48-hour course of prophylactic antibiotics with sufficient aerobic and anaerobic coverage to help minimize the incidence of antibiotic-related morbidities.Keywords
This publication has 21 references indexed in Scilit:
- Perioperative Antibiotics in the Setting of Microvascular Free Tissue Transfer: Current PracticesJournal of Reconstructive Microsurgery, 2010
- Infection of surgical wounds in the maxillofacial region and free flap donor sites with methicillin-resistant Staphylococcus aureusBritish Journal of Oral and Maxillofacial Surgery, 2006
- Factors influencing the development of wound infection following free-flap reconstruction for intra-oral cancerBritish Journal of Plastic Surgery, 2004
- Three-Dose vs Extended-Course Clindamycin Prophylaxis for Free-Flap Reconstruction of the Head and NeckJAMA Otolaryngology–Head & Neck Surgery, 2003
- The Role of Topical Antibiotic Prophylaxis in Patients Undergoing Contaminated Head and Neck Surgery With Flap ReconstructionThe Laryngoscope, 2001
- Comparison of ampicillin/sulbactam versus clindamycin in the prevention of infection in patients undergoing head and neck surgeryHead & Neck, 1997
- Antimicrobial prophylaxis for major head and neck surgery in cancer patients: sulbactam-ampicillin versus clindamycin-amikacinAntimicrobial Agents and Chemotherapy, 1992
- Prophylactic Antibiotics for Head and Neck Surgery With Flap ReconstructionJAMA Otolaryngology–Head & Neck Surgery, 1992
- Role of Prophylactic Antibiotics in Uncontaminated Neck DissectionsJAMA Otolaryngology–Head & Neck Surgery, 1991
- Antimicrobial prophylaxis for contaminated head and neck surgeryThe Laryngoscope, 1984